KCT0008318招募中Unknown
A Prospective study to estimate the effectiveness of evluation of midline crossover vessel using High frequency color doppler ultrasound in predicting the contralateral blood flow of the deep inferior epigastric artery perforator (DIEP) flap.
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- Female
入选标准
- •Among patients undergoing breast cancer surgery and reconstructive surgery at our hospital, patients who are scheduled to undergo deep subabdominal wall perforator flap are prospectively included as study subjects.
排除标准
- •Among patients undergoing breast cancer surgery and reconstructive surgery at our hospital, those who are planning to use implants, those who are scheduled to undergo self-tissue breast reconstruction with flaps other than the abdomen, those who have severe scars on the abdomen that make evaluation difficult, and those who refuse ultrasound examination are excluded.
研究者
相似试验
已完成
不适用
A prospective study to evaluate the effectiveness of dedicated breast positron emission tomography (dbPET) in patients undergoing neoadjuvant chemotherapy for breast cancerBreast cancerJPRN-UMIN000012517Department of gastroterological surgery, Graduate School of Medicine, Yokohama City University15
已完成
不适用
A prospective study to evaluate the effectiveness of dedicated breast positron emission tomography (dbPET) in patients required vacuum-assisted biopsyBreast cancerJPRN-UMIN000012516Department of gastroterological surgery, Graduate School of Medicine, Yokohama City University12
尚未招募
不适用
A prospective study to evaluate the effectiveness of positron emission mammography (PEM) in predicting the treatment outcome of chemotherapy in patients with breast cancer.brast cancerJPRN-UMIN000009314Department of Radiology, Graduate School of Medicine, Yokohama City University50
招募中
不适用
A study of a safe and non-invasive method for preventive screening for breast cancer and monitoring of breast cancer patients.CTRI/2020/03/023783IRAMAI Health Analytix Pvt Ltd
进行中（未招募）
2 期
A prospective study of investigating the efficacy of FOLFIRI plus Aflibercept as a 2nd line therapy after progression during FOLFOXIRI plus Bevacizumab in unrescetable / metastatic colorectal cancer (CRC) patients.Colorectal CancerJPRN-jRCTs071190003Oki Eiji35